Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06548776 · ClinicalTrials.gov registry record · NA

Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord

A NA study of Spinal Cord, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT06548776 is a NA study of Spinal Cord that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06548776, a NA study of Spinal Cord, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

To learn if MRS can effectively assess spinal cord lesions.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Magnetic Resonance Spectroscopy (MRS) Scan

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2024-09-04
Est. Completion 2028-07-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06548776

The ClinicalTrials.gov registry entry for NCT06548776 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Spectroscopy (MRS) Scan is the first listed.

NCT06548776 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06548776 about?

NCT06548776 is a clinical study titled "Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord". To learn if MRS can effectively assess spinal cord lesions.

What is the current status of trial NCT06548776?

This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2024-09-04. Estimated completion is 2028-07-31.

What conditions does trial NCT06548776 study?

This clinical trial studies the following conditions: Spinal Cord.

What interventions are being tested in trial NCT06548776?

The interventions under investigation include: Magnetic Resonance Spectroscopy (MRS) Scan (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06548776?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06548776 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.